Revision: April 23, 2026, 10:28 a.m.
01/29/2026 0221s
01/29/2026 0258s
23Apr2026... 1309h
2026 SESSION
26-2041
05/06
SENATE BILL 400
AN ACT relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.
SPONSORS: Sen. Gannon, Dist 23; Sen. Birdsell, Dist 19; Sen. Rochefort, Dist 1; Sen. Pearl, Dist 17; Rep. Barbour, Hills. 35; Rep. Creighton, Hills. 30; Rep. Vose, Rock. 5; Rep. L. Walsh, Rock. 15
COMMITTEE: Executive Departments and Administration
-----------------------------------------------------------------
AMENDED ANALYSIS
This bill requires the annual report by the therapeutic cannabis medical oversight board to include documentation of the board's review of currently approved and additional qualifying medical conditions, including the board's findings and recommendations, and citations to the medical and scientific evidence reviewed by the board.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
01/29/2026 0221s
01/29/2026 0258s
23Apr2026... 1309h 26-2041
05/06
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty-Six
AN ACT relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Therapeutic Cannabis Medical Oversight Board; Reporting Requirement. Amend RSA 126-X:12, VI to read as follows:
VI. On or before January 1 of each year, the board shall make a report to the president of the senate, the speaker of the house of representatives, the oversight committee on health and human services established under RSA 126-A:13, the board of medicine, and the board of nursing. The report shall include documentation of the board's reviews of currently approved and additional qualifying medical conditions, including the board's findings and recommendations, and citations to the medical and scientific evidence reviewed by the board.
2 Effective Date. This act shall take effect 60 days after its passage.